BioSpace News Archive

Twist Bioscience (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that Emily Leproust, Ph.D., chief executive officer, will participate in an analyst-led fireside chat at the Evercore ISI HealthCONx Conference on Thursday, November 29, 2018 at 8:45am Eastern Time at the Boston Harbor Hotel in Boston, MA.

Precision BioSciences and Servier today announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for PBCAR0191, an allogeneic anti-CD19 CAR T therapy for B-cell acute lymphoblastic leukemia (B-ALL) and non-Hodgkin lymphoma (NHL).

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Commission (EC) granted marketing authorization for ALUNBRIG (brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib

Series B funding will allow company to finalize development, regulatory submission, and commercialization of Verrix EVA™ BI System

Henretta brings extensive commercialization experience to the Board, as well as significant expertise in digital business transformation in the consumer product and wellness space.

DEPArray Technology Used for Detection and Isolation of Lymphoma and Multiple Myeloma Cells

Both treatment groups evidenced similar improvements in global psoriasis severity as measured by improvements in the Investigator’s Global Assessment (IGA) from baseline to Day 15.

Funding to be Provided by Consortium of EB Charities

Specialized Software Enhances Review Process for Radiology Reports To Help Improve Patient Care

Campaign Designed to Knock Your Socks Off with Compassionate Compression Kits